Literature DB >> 24766985

Drivers of hospitalization for patients with atrial fibrillation: Results from the Outcomes Registry for Better Informed Treatment of Atrial Fibrillation (ORBIT-AF).

Benjamin A Steinberg1, Sunghee Kim2, Gregg C Fonarow3, Laine Thomas2, Jack Ansell4, Peter R Kowey5, Kenneth W Mahaffey6, Bernard J Gersh7, Elaine Hylek8, Gerald Naccarelli9, Alan S Go10, James Reiffel11, Paul Chang12, Eric D Peterson13, Jonathan P Piccini13.   

Abstract

BACKGROUND: Atrial fibrillation (AF) is the most common cardiac dysrhythmia and contributes significantly to health care expenditures. We sought to assess the frequency and predictors of hospitalization in patients with AF.
METHODS: The ORBIT-AF registry is a prospective, observational study of outpatients with AF enrolled from June 29, 2010, to August 9, 2011. The current analysis included 9,484 participants with 1-year follow-up. Multivariable, logistic regression was used to identify baseline characteristics that were associated with first cause-specific hospitalization.
RESULTS: Overall, 31% of patients with AF studied (n = 2,963) had 1 or more hospitalizations per year and 10% (n = 983) had 2 or more. The most common hospitalization cause was cardiovascular (20 per 100 patient-years vs 3.3 bleeding vs 17 noncardiovascular, nonbleeding). Compared with those not hospitalized, hospitalized patients were more likely to have concomitant heart failure (42% vs 28%, P < .0001), higher mean CHADS2 (1 point for congestive heart failure, hypertension, age ≥75, or diabetes; 2 points for prior stroke or transient ischemic attack) scores (2.5 vs 2.2, P < .0001), and more symptoms (baseline European Heart Rhythm Association class severe symptoms 18% vs 13%, P < .0001). In multivariable analysis, heart failure (adjusted hazard ratio [HR] 1.57 for New York Heart Association III/IV vs none, P < .0001), heart rate at baseline (adjusted HR 1.11 per 10-beats/min increase >66, P < .0001), and AF symptom class (adjusted HR 1.37 for European Heart Rhythm Association severe vs none, P < .0001) were the major predictors of incident hospitalization.
CONCLUSIONS: Hospitalization is common in outpatients with AF and is independently predicted by heart failure and AF symptoms. Improved symptom control, rate control, and comorbid condition management should be evaluated as strategies to reduce health care use in these patients.
Copyright © 2014 Mosby, Inc. All rights reserved.

Entities:  

Mesh:

Year:  2014        PMID: 24766985      PMCID: PMC4006943          DOI: 10.1016/j.ahj.2014.02.003

Source DB:  PubMed          Journal:  Am Heart J        ISSN: 0002-8703            Impact factor:   4.749


  23 in total

1.  The increasing burden of atrial fibrillation compared with heart failure and myocardial infarction: a 15-year study of all hospitalizations in Australia.

Authors:  Christopher X Wong; Anthony G Brooks; Darryl P Leong; Kurt C Roberts-Thomson; Prashanthan Sanders
Journal:  Arch Intern Med       Date:  2012-05-14

2.  Rates and implications for hospitalization of patients ≥65 years of age with atrial fibrillation/flutter.

Authors:  Gerald V Naccarelli; Stephen S Johnston; Mehul Dalal; Jay Lin; Parag P Patel
Journal:  Am J Cardiol       Date:  2011-11-24       Impact factor: 2.778

3.  Assessing the direct costs of treating nonvalvular atrial fibrillation in the United States.

Authors:  Karin S Coyne; Clark Paramore; Susan Grandy; Marco Mercader; Matthew Reynolds; Peter Zimetbaum
Journal:  Value Health       Date:  2006 Sep-Oct       Impact factor: 5.725

4.  Outpatient treatment of recent-onset atrial fibrillation with the "pill-in-the-pocket" approach.

Authors:  Paolo Alboni; Giovanni L Botto; Nicola Baldi; Mario Luzi; Vitantonio Russo; Lorella Gianfranchi; Paola Marchi; Massimo Calzolari; Alberto Solano; Raffaele Baroffio; Germano Gaggioli
Journal:  N Engl J Med       Date:  2004-12-02       Impact factor: 91.245

5.  Radiofrequency catheter ablation of atrial fibrillation in older patients: outcomes and complications.

Authors:  Fred Kusumoto; Karin Prussak; Melissa Wiesinger; Tammy Pullen; Cynthia Lynady
Journal:  J Interv Card Electrophysiol       Date:  2009-01-16       Impact factor: 1.900

6.  Increasing trends in hospitalization for atrial fibrillation in the United States, 1985 through 1999: implications for primary prevention.

Authors:  Wendy A Wattigney; George A Mensah; Janet B Croft
Journal:  Circulation       Date:  2003-07-28       Impact factor: 29.690

7.  A method to determine the optimal intensity of oral anticoagulant therapy.

Authors:  F R Rosendaal; S C Cannegieter; F J van der Meer; E Briët
Journal:  Thromb Haemost       Date:  1993-03-01       Impact factor: 5.249

8.  Warfarin treatment in patients with atrial fibrillation: observing outcomes associated with varying levels of INR control.

Authors:  Christopher Ll Morgan; Phil McEwan; Andrzej Tukiendorf; Paul A Robinson; Andreas Clemens; Jonathan M Plumb
Journal:  Thromb Res       Date:  2008-12-04       Impact factor: 3.944

Review 9.  Anticoagulation control and prediction of adverse events in patients with atrial fibrillation: a systematic review.

Authors:  Yi Wan; Carl Heneghan; Rafael Perera; Nia Roberts; Jennifer Hollowell; Paul Glasziou; Clare Bankhead; Yongyong Xu
Journal:  Circ Cardiovasc Qual Outcomes       Date:  2008-11-05

10.  Cardiovascular and non-cardiovascular hospital admissions associated with atrial fibrillation: a Danish nationwide, retrospective cohort study.

Authors:  Christine Benn Christiansen; Jonas Bjerring Olesen; Gunnar Gislason; Morten Lock-Hansen; Christian Torp-Pedersen
Journal:  BMJ Open       Date:  2013-01-24       Impact factor: 2.692

View more
  31 in total

1.  Effect of Digoxin Use Among Medicaid Enrollees With Atrial Fibrillation.

Authors:  Demilade Adedinsewo; Junjun Xu; Pradyumna Agasthi; Adesoji Oderinde; Oluwatoyosi Adekeye; Rajesh Sachdeva; George Rust; Anekwe Onwuanyi
Journal:  Circ Arrhythm Electrophysiol       Date:  2017-05

Review 2.  Symptoms In Atrial Fibrillation: A Contemporary Review And Future Directions.

Authors:  Steven T Heidt; Anna Kratz; Kayvan Najarian; Afton L Hassett; Hakan Oral; Richard Gonzalez; Brahmajee K Nallamothu; Daniel Clauw; Hamid Ghanbari
Journal:  J Atr Fibrillation       Date:  2016-06-30

Review 3.  [Radiofrequency current or cryoballoon for ablation of atrial fibrillation? : Hot or cold?]

Authors:  B Reissmann; K-H Kuck; A Metzner
Journal:  Herz       Date:  2017-06       Impact factor: 1.443

4.  Symptom Clusters in Adults With Chronic Atrial Fibrillation.

Authors:  Megan Streur; Sarah J Ratcliffe; Jocasta Ball; Simon Stewart; Barbara Riegel
Journal:  J Cardiovasc Nurs       Date:  2017 May/Jun       Impact factor: 2.083

Review 5.  Risk Factor Management in Atrial Fibrillation.

Authors:  Axel Brandes; Marcelle D Smit; Bao Oanh Nguyen; Michiel Rienstra; Isabelle C Van Gelder
Journal:  Arrhythm Electrophysiol Rev       Date:  2018-06

6.  Feasibility and Usability of a Mobile Application to Assess Symptoms and Affect in Patients with Atrial Fibrillation: A Pilot Study.

Authors:  Hamid Ghanbari; Sardar Ansari; Michael Ghannam; Sangeeta Lathkar-Pradhan; Anna Kratz; Hakan Oral; Kayvan Najarian; Daniel Clauw; Brahmajee Nallamothu
Journal:  J Atr Fibrillation       Date:  2017-08-31

7.  Multimorbidity and the risk of hospitalization and death in atrial fibrillation: A population-based study.

Authors:  Alanna M Chamberlain; Alvaro Alonso; Bernard J Gersh; Sheila M Manemann; Jill M Killian; Susan A Weston; Margaret Byrne; Véronique L Roger
Journal:  Am Heart J       Date:  2016-12-09       Impact factor: 4.749

8.  Association of Multimorbidity with Cardiovascular Endpoints and Treatment Effectiveness in Patients 75 Years and Older with Atrial Fibrillation.

Authors:  J'Neka S Claxton; Alanna M Chamberlain; Pamela L Lutsey; Lin Y Chen; Richard F MacLehose; Lindsay G S Bengtson; Alvaro Alonso
Journal:  Am J Med       Date:  2020-04-19       Impact factor: 4.965

9.  Clinical Differences between Subtypes of Atrial Fibrillation and Flutter: Cross-Sectional Registry of 407 Patients.

Authors:  Eduardo Dytz Almeida; Raphael Boesche Guimarães; Laura Siga Stephan; Alexandre Kreling Medeiros; Katia Foltz; Roberto Tofani Santanna; Leonardo Martins Pires; Marcelo Lapa Kruse; Gustavo Glotz de Lima; Tiago Luiz Luz Leiria
Journal:  Arq Bras Cardiol       Date:  2015-05-19       Impact factor: 2.000

10.  Validity of electronic hospital discharge prescription records as a source of medication data for pharmacoepidemiological research.

Authors:  Laura Fanning; Lilian Vo; Jenni Ilomäki; J Simon Bell; Rohan A Elliott; Pēteris Dārziņš
Journal:  Ther Adv Drug Saf       Date:  2018-05-18
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.